← Leaderboards
Amanda Jean Stevenson
University Of Colorado
$3,821,323
Attributed
$3,821,323
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,821,323 · 2
By mechanism
R01$3,821,323 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado
Same institution · by research overlap
- Myron P. Gutmann$11,157,088
- Tania Barham$135,754
- Sara Yeatman$387,165
- Benjamin Domingue$149,831
- Leslie Root$156,404
Others in their field
Other Emerging Leaders on “Family”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$49,374,001
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,270,371
- Lynn Briscoe · Leidos Biomedical Research, Inc.$23,229,499
- Badri N Vardarajan · University Of Miami School Of Medicine$20,570,414
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
Research focus
FamilyHuman CapitalEvidence BaseExposure ToGeographic LocationsHouseholdEnrollmentEthnic OriginEconomic OutcomeExperimental StudyFertilityFundingCensusesHealth PromotionEducationEmploymentAmericanContraceptive MethodsClinicCodeColoradoCommunity SurveysFamily PlanningIncome
Grant awards (7)
Life course impacts of reduced access to contraception$629,982
R01 · FY2025 · HD · contact PI
Life course impacts of reduced access to contraception$681,884
R01 · FY2024 · HD · contact PI
Increased access to highly effective contraception: an opportunity dividend?$482,105
R01 · FY2024 · HD · contact PI
Increased access to highly effective contraception: an opportunity dividend?$486,973
R01 · FY2023 · HD · contact PI
Increased access to highly effective contraception: an opportunity dividend?$503,076
R01 · FY2022 · HD · contact PI
Increased access to highly effective contraception: an opportunity dividend?$504,442
R01 · FY2021 · HD · contact PI
Increased access to highly effective contraception: an opportunity dividend?$532,861
R01 · FY2020 · HD · contact PI